Abnormal T-cell function in B-cell chronic lymphocytic leukaemia (Q35104347)

6 August 2017

1 reference

title

Abnormal T-cell function in B-cell chronic lymphocytic leukaemia (English)

1 reference

6 August 2017

0 references

1 reference

0 references

Scrivener S

1

1 reference

6 August 2017

Goddard RV

series ordinal

2

1 reference

6 August 2017

Kaminski ER

series ordinal

3

1 reference

6 August 2017

Prentice AG

series ordinal

4

1 reference

6 August 2017

publication date

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

44

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

383-389

1 reference

Update on the biology of chronic lymphocytic leukemia

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

How B and T cells talk to each other

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

T-cell activation: integration of signals from the antigen receptor and costimulatory molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

T cells and CD45R expression in B-chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Distinctive selection mechanisms govern the T cell receptor repertoire of peripheral CD4-CD8- alpha/beta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Thymic selection: a matter of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Immunoregulatory cell dysfunction in chronic B-cell leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

On the mode of action of LFA-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

CD28/B7 system of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

The CD40 ligand. At the center of the immune universe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

CTLA-4 can function as a negative regulator of T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Acquired CD40-ligand deficiency in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Analysis of blood T-cell cytokine expression in B-chronic lymphocytic leukaemia: evidence for increased levels of cytoplasmic IL-4 in resting and activated CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8 T cells from B-CLL patients: impact on clonal B-cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Disruption of the IFN-gamma cytokine network in chronic lymphocytic leukemia contributes to resistance of leukemic B cells to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Major histocompatibility complex-restricted recognition of autologous chronic lymphocytic leukemia by tumor-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Expansion of CD4 T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819021000029993

10.1080/1042819021000029993

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference